Pseudopodial and β-arrestin-interacting proteomes from migrating breast cancer cells upon PAR2 activation

被引:20
作者
Parisis, Nikolaos [1 ]
Metodieva, Gergana [1 ]
Metodiev, Metodi V. [1 ]
机构
[1] Univ Essex, Dept Biol Sci, Prote Unit, Colchester CO4 3SQ, Essex, England
关键词
PAR-2; Pseudopodium; Beta-arrestin; Cell migration; Proteomics; GEL-ELECTROPHORESIS; BASEMENT-MEMBRANE; MASS-SPECTROMETRY; UP-REGULATION; FACTOR VIIA; RECEPTOR; PROTEIN; EXPRESSION; INVASION; ENDOCYTOSIS;
D O I
10.1016/j.jprot.2012.12.024
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Metastatic cancer cells form pseudopodia (PD) to facilitate their migration. The proteinase-activated receptor-2 (PAR-2) transduces migratory signals from proteases, and it forms protein complexes with p-arrestin and other signalling molecules that are enriched in pseudopodia. More generally, however, pseudopodial regulation is poorly understood. Here, we purified the pseudopodial proteomes of breast cancer cells after activation of the endogenous PAR-2 and we combined gel-based approaches with label-free high-resolution mass spectrometry to identify proteins that accumulate at the pseudopodia upon PAR-2-mediated migration. We identified >410 proteins in the cell body and >380 in the pseudopodia upon PAR2 activation, of which 93 were enriched in the pseudopodia. One of the pathways strongly enriched in the PD was the clathrin-mediated endocytosis signalling pathway, highlighting the importance of the scaffolding function of p-arrestin in PAR-2 signalling via its endocytosis. We therefore immunoprecipitated beta-arrestins, and with mass spectrometry we identified 418 novel putative interactors. These data revealed novel p-arrestin functions that specifically control PAR-2-regulated signalling in migrating breast cancer cells but also showed that some p-arrestin functions are universal between GPCRs and cell types. In conclusion, this study reveals novel proteins and signalling pathways potentially important for migration of breast cancer cells. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:91 / 106
页数:16
相关论文
共 56 条
  • [1] Proteome profiling of breast tumors by gel electrophoresis and nanoscale electrospray ionization mass spectrometry
    Alldridge, Louise
    Metodieva, Gergana
    Greenwood, Christina
    Al-Janabi, Khalid
    Thwaites, Laura
    Sauven, Paul
    Metodiev, Metodi
    [J]. JOURNAL OF PROTEOME RESEARCH, 2008, 7 (04) : 1458 - 1469
  • [2] Impaired wound healing in mice lacking the basement membrane protein nidogen 1
    Baranowsky, Anke
    Mokkapati, Sharada
    Bechtel, Manuela
    Kruegel, Jenny
    Miosge, Nicolai
    Wickenhauser, Claudia
    Smyth, Neil
    Nischt, Roswitha
    [J]. MATRIX BIOLOGY, 2010, 29 (01) : 15 - 21
  • [3] Proteomic characterization of harvested pseudopodia with differential gel electrophoresis and specific antibodies
    Beckner, ME
    Chen, X
    An, JY
    Day, BW
    Pollack, IF
    [J]. LABORATORY INVESTIGATION, 2005, 85 (03) : 316 - 327
  • [4] Ligand cross-reactivity within the protease-activated receptor family
    Blackhart, BD
    Emilsson, K
    Nguyen, D
    Teng, W
    Martelli, AJ
    Nystedt, S
    Sundelin, J
    Scarborough, RM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) : 16466 - 16471
  • [5] ERK and RhoA differentially regulate pseudopodia growth and retraction during chemotaxis
    Brahmbhatt, AA
    Klemke, RL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (15) : 13016 - 13025
  • [6] A network-based analysis of systemic inflammation in humans
    Calvano, SE
    Xiao, WZ
    Richards, DR
    Felciano, RM
    Baker, HV
    Cho, RJ
    Chen, RO
    Brownstein, BH
    Cobb, JP
    Tschoeke, SK
    Miller-Graziano, C
    Moldawer, LL
    Mindrinos, MN
    Davis, RW
    Tompkins, RG
    Lowry, SF
    [J]. NATURE, 2005, 437 (7061) : 1032 - 1037
  • [7] Guiding cell migration through directed extension and stabilization of pseudopodia
    Chodniewicz, D
    Klemke, RL
    [J]. EXPERIMENTAL CELL RESEARCH, 2004, 301 (01) : 31 - 37
  • [8] Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases
    Colombo, E.
    Alcalay, M.
    Pelicci, P. G.
    [J]. ONCOGENE, 2011, 30 (23) : 2595 - 2609
  • [9] A polymorphic protease-activated receptor 2 (PAR2) displaying reduced sensitivity to trypsin and differential responses to PAR agonists
    Compton, SJ
    Cairns, JA
    Palmer, KJ
    Al-Ani, B
    Hollenberg, MD
    Walls, AF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (50) : 39207 - 39212
  • [10] Differential expression of protease-activated receptors-1 and-2 in stromal fibroblasts of normal, benign, and malignant human tissues
    D'Andrea, MR
    Derian, CK
    Santulli, RJ
    Andrade-Gordon, P
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (06) : 2031 - 2041